Floatz logo

Sibutramine

Polycystic Ovaries Syndrome

Hippocration General HospitalSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

66 Active assets in the Polycystic Ovaries Syndrome cohort.

Asset / SponsorPhaseRating
Hcg
Eman Basuni Ebrahim Mowad
Phase 4BBB
Semaglutide
Methodist Health System
Phase 4BBB
Liraglutide
Peking University Third Hospital
Phase 4BBB
Drospirenone
Ege University
Phase 4BBB
FOLLITROPIN BETA
Universitair Ziekenhuis Brussel
Phase 4BBB

View all 50 →

Same molecule, other indications

Sibutramine is also rated in:

binge eating disorderDormant
BBB
Indicative ·
76 / 100
View asset →
hypertensive disorderDormant
BB
Indicative ·
71 / 100
View asset →
obesity disorderDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →